| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | -1.55% | +2.69% | -4.24% | -6.68% | — |
| 14d | 3 | +33.33% | +7.71% | +3.55% | +4.16% | +4.43% | — |
| 30d | 3 | +66.67% | -1.55% | +5.97% | +0.76% | +0.76% | — |
| 60d | 3 | +66.67% | +1.82% | +5.34% | -3.52% | -19.85% | — |
| 90d | 3(1 pending) | +50.00% | +6.91% | +12.80% | -5.90% | -5.90% | — |
| 180d | 3(2 pending) | +100.00% | -13.38% | +29.29% | -42.67% | -42.67% | — |
| 1y | 3(2 pending) | +0.00% | +63.38% | +37.01% | +26.37% | +26.37% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE SVP, Finance | 9,586 | $2.31 | $22.1K | 124,517 | Apr 21, 2026 | Apr 23, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE SVP, Finance | 4,167 | $1.72 | $7.2K | 130,322 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,827 | — | — | 50,827 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 179,691 | — | — | 179,691 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE SVP, Finance | 9,601 | $1.41 | $13.5K | 130,663 | Apr 21, 2025 | Apr 23, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 128,093 | — | — | 128,093 | Jan 24, 2025 | Jan 28, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,232 | — | — | 137,990 | Jan 24, 2025 | Jan 28, 2025 ↗ | View → |